Clinical Trial Update: Plasma Betatrophin Levels in Non-alcoholic Fatty Liver Disease

View source ↗

Summary

This clinical trial update reports on a completed study evaluating plasma betatrophin levels in individuals with non-alcoholic fatty liver disease.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-alcoholic Fatty Liver Disease

Snippet

Sponsor: Gulhane School of Medicine | Conditions: Non-alcoholic Fatty Liver Disease | Status: COMPLETED